A Change in Vaccine Efficacy and Duration of Protection Explains Recent Rises in Pertussis Incidence in the United States

• Manoj Gambhir ,

  * E-mail: manoj.gambhir@monash.edu

  Affiliations Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia, Modeling Unit, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, United States of America, IHRC, Inc., Atlanta, Georgia, United States of America

  ⨯
• Thomas A. Clark,

  Affiliation Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, NCIRD, CDC, Atlanta, Georgia, United States of America

  ⨯
• Simon Cauchemez,

  Affiliations Medical Research Council Centre for Outbreak Analysis and Modelling, Imperial College London, London, United Kingdom, Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur, Paris, France

  ⨯
• Sara Y. Tartof,

  Affiliation Kaiser Permanente Southern California, Kaiser Permanente Research, Department of Research & Evaluation, Pasadena, California, United States of America

  ⨯
• David L. Swerdlow,

  Affiliations Modeling Unit, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, United States of America, Office of Science and Integrative Programs, NCIRD, CDC, Atlanta, Georgia, United States of America

  ⨯
• Neil M. Ferguson

  Affiliation Medical Research Council Centre for Outbreak Analysis and Modelling, Imperial College London, London, United Kingdom

  ⨯